Astellas Pharma (China)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (China), China, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
54%
Total
Publications
264
Total Open
Publications
142
Total
Citations
12K
Open Access
Percentage
54%
Total
Publications
264
Total Open
Publications
142
Total
Citations
12K
Breakdown
Publisher Open
24%
Both
20%
Other Platform Open
10%
Closed
46%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
28
Hybrid 34%
39
No Guarantees 42%
49
Other Platform Open
Domain 82%
64
Institution 18%
14
Preprint 15%
12
Other Internet 15%
12
Public 9%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 64 |
Europe PMC | Domain | 34 |
Research Square | Preprint | 8 |
Semantic Scholar | Public | 7 |
DOI | Other Internet | 4 |
Taylor and Francis Group - Dove Medical Press | Other Internet | 3 |
The University of Manchester - Research Explorer | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes | Institution | 2 |
California Digital Library - eScholarship | Other Internet | 2 |
whiterose.ac.uk OAI-PMH Repository | Institution | 1 |